South Korea · Delayed Price · Currency is KRW Hanmi Science Statistics
Total Valuation
Hanmi Science has a market cap or net worth of KRW 1.93 trillion. The enterprise value is 2.00 trillion.
| Market Cap | 1.93T |
| Enterprise Value | 2.00T |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Hanmi Science has 67.71 million shares outstanding. The number of shares has increased by 0.12% in one year.
| Current Share Class | 67.71M |
| Shares Outstanding | 67.71M |
| Shares Change (YoY) | +0.12% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | 48.25% |
| Owned by Institutions (%) | 14.72% |
| Float | 23.51M |
Valuation Ratios
The trailing PE ratio is 14.17.
| PE Ratio | 14.17 |
| Forward PE | n/a |
| PS Ratio | 1.40 |
| PB Ratio | 1.93 |
| P/TBV Ratio | 1.96 |
| P/FCF Ratio | 49.52 |
| P/OCF Ratio | 33.45 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.90, with an EV/FCF ratio of 51.38.
| EV / Earnings | 14.69 |
| EV / Sales | 1.45 |
| EV / EBITDA | 11.90 |
| EV / EBIT | 12.61 |
| EV / FCF | 51.38 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 0.19.
| Current Ratio | 0.87 |
| Quick Ratio | 0.53 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 2.58 |
| Debt / FCF | 4.84 |
| Interest Coverage | 5.99 |
Financial Efficiency
Return on equity (ROE) is 14.60% and return on invested capital (ROIC) is 5.36%.
| Return on Equity (ROE) | 14.60% |
| Return on Assets (ROA) | 2.78% |
| Return on Invested Capital (ROIC) | 5.36% |
| Return on Capital Employed (ROCE) | 6.06% |
| Weighted Average Cost of Capital (WACC) | 6.84% |
| Revenue Per Employee | 2.90B |
| Profits Per Employee | 285.74M |
| Employee Count | 476 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 9.22 |
Taxes
In the past 12 months, Hanmi Science has paid 16.12 billion in taxes.
| Income Tax | 16.12B |
| Effective Tax Rate | 10.63% |
Stock Price Statistics
The stock price has decreased by -23.21% in the last 52 weeks. The beta is 0.50, so Hanmi Science's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -23.21% |
| 50-Day Moving Average | 36,315.00 |
| 200-Day Moving Average | 38,702.75 |
| Relative Strength Index (RSI) | 28.03 |
| Average Volume (20 Days) | 145,087 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hanmi Science had revenue of KRW 1.38 trillion and earned 136.01 billion in profits. Earnings per share was 2,007.05.
| Revenue | 1.38T |
| Gross Profit | 319.50B |
| Operating Income | 63.46B |
| Pretax Income | 151.67B |
| Net Income | 136.01B |
| EBITDA | 72.87B |
| EBIT | 63.46B |
| Earnings Per Share (EPS) | 2,007.05 |
Balance Sheet
The company has 116.03 billion in cash and 188.20 billion in debt, with a net cash position of -72.18 billion or -1,065.91 per share.
| Cash & Cash Equivalents | 116.03B |
| Total Debt | 188.20B |
| Net Cash | -72.18B |
| Net Cash Per Share | -1,065.91 |
| Equity (Book Value) | 1.00T |
| Book Value Per Share | 14,752.29 |
| Working Capital | -59.36B |
Cash Flow
In the last 12 months, operating cash flow was 57.59 billion and capital expenditures -18.69 billion, giving a free cash flow of 38.90 billion.
| Operating Cash Flow | 57.59B |
| Capital Expenditures | -18.69B |
| Depreciation & Amortization | 9.41B |
| Net Borrowing | -31.74B |
| Free Cash Flow | 38.90B |
| FCF Per Share | 574.48 |
Margins
Gross margin is 23.14%, with operating and profit margins of 4.60% and 9.85%.
| Gross Margin | 23.14% |
| Operating Margin | 4.60% |
| Pretax Margin | 10.99% |
| Profit Margin | 9.85% |
| EBITDA Margin | 5.28% |
| EBIT Margin | 4.60% |
| FCF Margin | 2.82% |
Dividends & Yields
This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 0.95%.
| Dividend Per Share | 300.00 |
| Dividend Yield | 0.95% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 9.96% |
| Buyback Yield | -0.12% |
| Shareholder Yield | 0.83% |
| Earnings Yield | 7.06% |
| FCF Yield | 2.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 28, 2022. It was a forward split with a ratio of 1.02.
| Last Split Date | Dec 28, 2022 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Hanmi Science has an Altman Z-Score of 4.93 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.93 |
| Piotroski F-Score | 4 |